Skip to content

Checked

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07599813 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 2
Interventional
Planned enrollment
280
Participants, all sites
U.S. sites
33
In 18 states

Study details

Conditions
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic, Dermatologic Disease, Eczema, Eczema Atopic Dermatitis, Eczema, Atopic
Sponsor
Apollo Therapeutics Ltd (Industry)
Ages
18 to 65 years
Sex
All
Healthy volunteers
Not accepted
Start
05/28/2026
Primary completion (expected)
10/31/2027
Last updated by sponsor
08/28/2026

Full eligibility rules, contacts and site names: NCT07599813 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Alabama: Birmingham (2)
  • Arizona: Phoenix
  • Arkansas: Bryant
  • California: Los Angeles (3), Huntington Beach, Northridge, Sacramento, Tarzana
  • Colorado: Wheat Ridge
  • Florida: Miami (2), Cape Coral, Hollywood, North Lauderdale, North Miami Beach, Tampa
  • Georgia: Savannah
  • Idaho: Meridian
  • Illinois: Skokie
  • Indiana: Clarksville, Indianapolis
  • Maryland: Pasadena
  • Nevada: Reno
  • New Jersey: Clifton
  • New York: New York
  • North Dakota: Fargo
  • Ohio: Columbus
  • Pennsylvania: Camp Hill, Pittsburgh
  • Texas: San Antonio

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 08/28/2026